All 1 tracked stories fall under one category: market-trends. AstraZeneca Plc is most often covered alongside Bank of America Corp DE, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 12.7 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about AstraZeneca Plc
All 1 tracked stories fall under one category: market-trends. AstraZeneca Plc is most often covered alongside Bank of America Corp DE, which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 12.7 across the same-window beat baseline. The 5 average consequence score is below the beat benchmark of 6.6 in the same window. We currently track 1 Healthcare story that mention AstraZeneca Plc, all published on June 28, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 21 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering AstraZeneca Plc. Shared-story counts are live from our verified record — not editorial picks.
Six major institutional investors have collectively added over 3.8 million AstraZeneca shares across recent quarters, signaling strong professional confidence in the company's diversified healthcare portfolio spanning oncology, cardiovascular, respiratory, and rare disease treatments. The sustained buying pattern highlights institutional conviction in AstraZeneca's ability to deliver innovative therapies that address critical unmet medical needs.
